Capula Management’s Immunogen Inc IMGN Stock Holding History

Capula Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-111,320	Closed	-$2.1M	–	696
2023 Q2	$2.1M	Buy	+111,320	New	+$1.31M	0.05%	138

Other funds holding IMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capula Management's IMGN Position: Q3 2023 in Review

Capula Management sold out of Immunogen Inc (IMGN) in Q3 2023, closing a stake of 111,320 shares — an estimated $2.1M sold.

Capula Management first reported a position in IMGN in Q2 2023 and held it in 1 quarter. The position peaked at $2.1M in Q2 2023. 275 funds tracked by Wall St. Rank hold IMGN as of Q3 2023.

Capula Management reported no remaining Immunogen Inc position as of Q3 2023 after selling out during the quarter.
Capula Management sold 111,320 Immunogen Inc shares in Q3 2023, an estimated $2.1M.
Capula Management first reported a position in Immunogen Inc in Q2 2023 and held it in 1 quarter.
Capula Management's Immunogen Inc position peaked at $2.1M in Q2 2023.
275 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2023.

Based on Capula Management's 13F filing for Q3 2023, filed 3 Nov 2023.